Anavex Life Sciences Corp (AVXL)

[W&T Capital LLC]

Well this info from IR confirms all 32 patients will be included in next data set.
Thank you for your email and continued interest in Anavex Life Sciences Corp. (OTCQX: AVXL).



Full PART A data from the Phase 2a trial of ANAVEX 2-73 is expected by year end.



Please do not hesitate to contact our office if we can be of further assistance.



On behalf of Anavex Life Sciences Corp.,



Christine Payne
Primoris Group Inc.

Toll Free (North America): 1 [phone]
Outside North America: [phone]
Fax: [phone]